464 related articles for article (PubMed ID: 27157263)
1. Evidences for the Anti-panic Actions of Cannabidiol.
Soares VP; Campos AC
Curr Neuropharmacol; 2017; 15(2):291-299. PubMed ID: 27157263
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
Schier AR; Ribeiro NP; Silva AC; Hallak JE; Crippa JA; Nardi AE; Zuardi AW
Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S104-10. PubMed ID: 22729452
[TBL] [Abstract][Full Text] [Related]
3. Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats.
Campos AC; de Paula Soares V; Carvalho MC; Ferreira FR; Vicente MA; Brandão ML; Zuardi AW; Zangrossi H; Guimarães FS
Psychopharmacology (Berl); 2013 Mar; 226(1):13-24. PubMed ID: 23007604
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.
Linge R; Jiménez-Sánchez L; Campa L; Pilar-Cuéllar F; Vidal R; Pazos A; Adell A; Díaz Á
Neuropharmacology; 2016 Apr; 103():16-26. PubMed ID: 26711860
[TBL] [Abstract][Full Text] [Related]
5. The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae).
Twardowschy A; Castiblanco-Urbina MA; Uribe-Mariño A; Biagioni AF; Salgado-Rohner CJ; Crippa JA; Coimbra NC
J Psychopharmacol; 2013 Dec; 27(12):1149-59. PubMed ID: 23926240
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Zuardi AW; Crippa JA; Hallak JE; Moreira FA; Guimarães FS
Braz J Med Biol Res; 2006 Apr; 39(4):421-9. PubMed ID: 16612464
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.
Gomes FV; Del Bel EA; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():43-7. PubMed ID: 23791616
[TBL] [Abstract][Full Text] [Related]
8. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors.
Soares Vde P; Campos AC; Bortoli VC; Zangrossi H; Guimarães FS; Zuardi AW
Behav Brain Res; 2010 Dec; 213(2):225-9. PubMed ID: 20457188
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.
de Mello Schier AR; de Oliveira Ribeiro NP; Coutinho DS; Machado S; Arias-Carrión O; Crippa JA; Zuardi AW; Nardi AE; Silva AC
CNS Neurol Disord Drug Targets; 2014; 13(6):953-60. PubMed ID: 24923339
[TBL] [Abstract][Full Text] [Related]
10. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S; Kloiber S; Le Foll B
Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
[TBL] [Abstract][Full Text] [Related]
11. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.
Fogaça MV; Reis FM; Campos AC; Guimarães FS
Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837
[TBL] [Abstract][Full Text] [Related]
12. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
Melas PA; Scherma M; Fratta W; Cifani C; Fadda P
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469
[TBL] [Abstract][Full Text] [Related]
14. Biological bases for a possible effect of cannabidiol in Parkinson's disease.
Ferreira-Junior NC; Campos AC; Guimarães FS; Del-Bel E; Zimmermann PMDR; Brum Junior L; Hallak JE; Crippa JA; Zuardi AW
Braz J Psychiatry; 2020 Apr; 42(2):218-224. PubMed ID: 31314869
[TBL] [Abstract][Full Text] [Related]
15. Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT₁A receptors and stressful experiences.
Marinho AL; Vila-Verde C; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Jun; 286():49-56. PubMed ID: 25701682
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol as a potential treatment for psychosis.
Schubart CD; Sommer IE; Fusar-Poli P; de Witte L; Kahn RS; Boks MP
Eur Neuropsychopharmacol; 2014 Jan; 24(1):51-64. PubMed ID: 24309088
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors.
Campos AC; Ferreira FR; Guimarães FS
J Psychiatr Res; 2012 Nov; 46(11):1501-10. PubMed ID: 22979992
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
Sartim AG; Guimarães FS; Joca SR
Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol as a Potential Treatment for Anxiety Disorders.
Blessing EM; Steenkamp MM; Manzanares J; Marmar CR
Neurotherapeutics; 2015 Oct; 12(4):825-36. PubMed ID: 26341731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
